Business
ReWalk Announces Binding Offer to Deutsche Gesetzliche Unfallversicherung (DGUV) - German Social Accident Insurance
83 million Germans, covered for work and commuting-related accidents, have the opportunity to access ReWalk products if the requirements and personal
About this update from Lifeward Ltd.
[{"type":"text","content":"83 million Germans, covered for work and commuting-related accidents, have the opportunity to access ReWalk products if the requirements and personal suitability are met\n\n\nMARLBOROUGH, Mass. and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) (\"ReWalk\" or the \"Company\"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer by DGUV (Deutsche Gesetzliche Unfallversicherung / The German Social Accident Insurance) to provide qualified spinal cord injury (SCI) patients with the ReWalk 6.0 robotic exoskeleton device. This binding offer applies for the provision of ReWalk Exoskeletons for all insured persons of the 36 different DGUV members/insurances. In 2018, nearly 83 million Germans were insured against work-related, commuting and school accidents and against occupational diseases under DGUV. \n\n \n \n \n \n \n \n\n \nQualified SCI patients who are beneficiaries of DGUV have the opportunity to be supplied with a ReWalk 6.0 exoskeleton for home and community use. Additionally, the necessary training and device support will be provided to those who have suffered an at-work or commute to work or school-related incident, and who are deemed eligible for the program. \n\"Germany's health care system is a world leader in establishing new standards of care for their population,\" said Larry Jasinski, CEO of ReWalk. \"This new national process will change many lives, and alters the landscape by defining exoskeletal ReWalking as a lifestyle path provided by the health care system. Building a defined process where clinicians and injured individuals can properly obtain this technology to enable walking sets the standard not only for Germany, but all other countries.\"\nWe have placed over 580 ReWalk exoskeletons to date worldwide. The Company received FDA clearance in 2014, and the CE Mark in 2012. The Company has been working with SCI patients around the world to provide devices to qualified users, in addition to working with insurers to establish national procurement policies. \nHow it works: ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with lower-limb disabilities, such as paraplegia, to stand upright and to walk. The user initiates mob...